CEO of Publicly Traded Firm Falsifies and Fabricates Bank Records in $212,000,000 Investment Fraud Scheme: DOJ
The former CEO of a publicly traded healthcare services company has been sentenced to five years in prison for his role in a $212.5 million investment fraud scheme.
The U.S. Department of Justice (DOJ) says Parmjit Parmar, also known as Paul Parmar, pleaded guilty to conspiracy to commit securities fraud and was sentenced on May 5, 2026.
Prosecutors say Parmar, 55, of Colts Neck, New Jersey, was also sentenced to three years of supervised release and ordered to pay more than $125 million in victim restitution.
The DOJ says Parmar and his co-conspirators orchestrated a scheme from May 2015 through September 2017 to defraud a private investment firm and others in connection with a transaction to take private a healthcare services company traded on the London Stock Exchange’s Alternative Investment Market.
To fund the transaction, a private investment firm contributed about $82.5 million, while a consortium of financial institutions contributed another $130 million.
Prosecutors say the conspirators used fraudulent methods to inflate the value of the company, including phony customers, altered bank statements and fabricated bank records tied to subsidiary entities.
The DOJ says the conspirators also funneled proceeds from secondary offerings through bank accounts they controlled and used the money for purposes unrelated to acquiring the purported targets.
The scam was uncovered in September 2017, when Parmar and his co-conspirators resigned or were terminated. The company and affiliated entities filed for bankruptcy on March 16, 2018, attributing the financial collapse in large part to the fraud scheme.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Prospects for the opening of the Hormuz Strait are overshadowed, Asian bonds under pressure: 2Y Japanese bond yield approaches 2%, 3Y Korean bond yield rises to highest level since 2022
With high oil prices, short-term bond yields in South Korea and Japan have risen.
5% US Treasury pressure weighs on global assets, while Australian government bonds open up a window for allocation? Fixed income giant Pimco calls the rate hike expectations too aggressive
Pacific Investment Management Company (Pimco) holds a constructive view on Australian bonds, believing that market expectations for rate hikes are too high. Pimco stated that the rate hike cycle in Australia has been "fully priced in," and cracks are beginning to appear in the economy, making Australian bonds look attractive, especially in the 5- to 10-year segment of the yield curve.
Only a few stocks are rising! Goldman Sachs warns: US stock market breadth hits the worst level since the 2000 internet bubble, with rare divergence in bond volatility
Flood, a Goldman Sachs partner, believes that leading AI companies are propping up the market indexes, while median stocks have fallen 16% from their highs. More unusually, Garrett, the head of derivatives trading at Goldman Sachs, warns that the bond volatility MOVE index is at an extremely high percentile, yet the VIX remains subdued. Jonathan Krinsky, a strategist at BTIG, points out that while total hedge fund leverage is rising, net leverage is falling, indicating a contradiction of "increasing exposure without increasing direction," and warns: "Something has to give."
Hyperliquid’s big test: Can institutional demand absorb $100M in whale selling?
Crypto prices
More
